Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Interleukin-6 Guided Treatment With Dexamethasone or Tocilizumab in Patients Hospitalized With Acute Respiratory Symptoms - a Feasibility Study

NCT07334379 is registered in ClinicalTrials.gov with Lorenzo delSorbo as lead sponsor.

NCT NCT07334379
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07334379 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Interleukin-6 Guided Treatment With Dexamethasone or Tocilizumab in Patients Hospitalized With Acute Respiratory Symptoms - a Feasibility Study
Lead sponsor
Lorenzo delSorbo
Phase
Phase 2
Overall status
Recruiting
Start date
October 20, 2025
Completion date
February 26, 2027
Enrollment
60 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

acute hypoxemic respiratory failure